These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23658773)

  • 1. Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
    Powell TJ; Peng Y; Berthoud TK; Blais ME; Lillie PJ; Hill AV; Rowland-Jones SL; McMichael AJ; Gilbert SC; Dong T
    PLoS One; 2013; 8(5):e62778. PubMed ID: 23658773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.
    McMahon M; Asthagiri Arunkumar G; Liu WC; Stadlbauer D; Albrecht RA; Pavot V; Aramouni M; Lambe T; Gilbert SC; Krammer F
    Front Immunol; 2019; 10():2005. PubMed ID: 31497029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of CD8
    Evans TG; Castellino F; Kowalik Dobczyk M; Tucker G; Walley AM; Van Leuven K; Klein J; Rutkowski K; Ellis C; Eagling-Vose E; Treanor J; van Baalen C; Filkov E; Laurent C; Thacker J; Asher J; Donabedian A
    Lancet Microbe; 2024 Jul; 5(7):645-654. PubMed ID: 38729196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo.
    Khodamoradi S; Shenagari M; Kheiri MT; Sabahi F; Jamali A; Heidari A; Ashrafkhani B
    Arch Virol; 2018 Apr; 163(4):877-886. PubMed ID: 29270718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
    Boyd AC; Ruiz-Hernandez R; Peroval MY; Carson C; Balkissoon D; Staines K; Turner AV; Hill AV; Gilbert SC; Butter C
    Vaccine; 2013 Jan; 31(4):670-5. PubMed ID: 23200938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.
    Di Mario G; Sciaraffia E; Facchini M; Gubinelli F; Soprana E; Panigada M; Bernasconi V; Garulli B; Siccardi A; Donatelli I; Castrucci MR
    Pathog Glob Health; 2017 Mar; 111(2):76-82. PubMed ID: 28079473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.
    Lillie PJ; Berthoud TK; Powell TJ; Lambe T; Mullarkey C; Spencer AJ; Hamill M; Peng Y; Blais ME; Duncan CJ; Sheehy SH; Havelock T; Faust SN; Williams RL; Gilbert A; Oxford J; Dong T; Hill AV; Gilbert SC
    Clin Infect Dis; 2012 Jul; 55(1):19-25. PubMed ID: 22441650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
    Berthoud TK; Hamill M; Lillie PJ; Hwenda L; Collins KA; Ewer KJ; Milicic A; Poyntz HC; Lambe T; Fletcher HA; Hill AV; Gilbert SC
    Clin Infect Dis; 2011 Jan; 52(1):1-7. PubMed ID: 21148512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.
    Magini D; Giovani C; Mangiavacchi S; Maccari S; Cecchi R; Ulmer JB; De Gregorio E; Geall AJ; Brazzoli M; Bertholet S
    PLoS One; 2016; 11(8):e0161193. PubMed ID: 27525409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination.
    Donnelly JJ; Friedman A; Ulmer JB; Liu MA
    Vaccine; 1997 Jun; 15(8):865-8. PubMed ID: 9234535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.
    Antrobus RD; Berthoud TK; Mullarkey CE; Hoschler K; Coughlan L; Zambon M; Hill AV; Gilbert SC
    Mol Ther; 2014 Jan; 22(1):233-8. PubMed ID: 23831594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
    Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
    van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
    Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
    Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.
    Fu TM; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
    J Virol; 1997 Apr; 71(4):2715-21. PubMed ID: 9060624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF; Rimmelzwaan GF; de Vries RD
    Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus.
    Donnelly JJ; Friedman A; Martinez D; Montgomery DL; Shiver JW; Motzel SL; Ulmer JB; Liu MA
    Nat Med; 1995 Jun; 1(6):583-7. PubMed ID: 7585127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.